APA (7th ed.) Citation

van Vlerken, L. G., Huisman, E. J., van Soest, H., Boland, G. J., Drenth, J. P. H., Siersema, P. D., . . . van Erpecum, K. J. (2012). Ribavirin rather than PEG-interferon pharmacodynamics predict nonresponse to antiviral therapy in naive chronic hepatitis C patients. Journal of Viral Hepatitis, 19(1), 39. https://doi.org/10.1111/j.1365-2893.2010.01399.x

Chicago Style (17th ed.) Citation

van Vlerken, L. G., E. J. Huisman, H. van Soest, G. J. Boland, J. P. H. Drenth, P. D. Siersema, D. M. Burger, and K. J. van Erpecum. "Ribavirin Rather than PEG-interferon Pharmacodynamics Predict Nonresponse to Antiviral Therapy in Naive Chronic Hepatitis C Patients." Journal of Viral Hepatitis 19, no. 1 (2012): 39. https://doi.org/10.1111/j.1365-2893.2010.01399.x.

MLA (9th ed.) Citation

van Vlerken, L. G., et al. "Ribavirin Rather than PEG-interferon Pharmacodynamics Predict Nonresponse to Antiviral Therapy in Naive Chronic Hepatitis C Patients." Journal of Viral Hepatitis, vol. 19, no. 1, 2012, p. 39, https://doi.org/10.1111/j.1365-2893.2010.01399.x.